Current Status and Future Challenges of Liquid Biopsy
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: 10 December 2024 | Viewed by 5933
Special Issue Editors
Interests: lung cancer; circulating tumor DNA; liquid biopsy; acquired resistance mechanism
Interests: lung cancer; circulating tumor DNA; liquid biopsy; acquired resistance mechanism
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Liquid biopsy is one of the biomarker detection techniques that is expected to expand its clinical applications in the near future. In addition to its role as a genetic test to explore predictive biomarkers for cancer treatment, liquid biopsy can detect minimal residual disease (MRD) after curative-intent treatment, meaning that it can detect disease recurrence prior to radiological examination.
In this Special Issue, we aim to publish recent advances in liquid biopsy from various perspectives, including basic research, translational data, clinical observations and clinical trials, as well as comprehensive reviews that focus on liquid biopsy in cancers, including but not limited to lung cancer, urothelial cancer, renal cell carcinoma, digestive cancer and breast cancer.
This Special Issue will cover all aspects of recent advances in liquid biopsy, including circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), circulating cell-free RNA, extracellular vesicles, and tumor-educated platelet (TEP). We invite all scientists working in the field of liquid biopsy to participate in this Special Issue. Original research articles, reviews, or short perspective articles on all aspects related to liquid biopsy are welcomed.
Dr. Shuta Ohara
Dr. Kenichi Suda
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liquid biopsy
- biomarker
- minimal residual disease (MRD)
- circulating tumor DNA (ctDNA)
- tumor-educated platelet (TEP)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.